Atıf Formatları
Bioevaluation of Spiro N-Propargylic β-Enaminones as Anti-Breast Cancer Agents: In Vitro and Molecular Docking Studies
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

H. ATMACA İLHAN Et Al. , "Bioevaluation of Spiro N-Propargylic β-Enaminones as Anti-Breast Cancer Agents: In Vitro and Molecular Docking Studies," Chemistry and Biodiversity , vol.20, no.11, 2023

ATMACA İLHAN, H. Et Al. 2023. Bioevaluation of Spiro N-Propargylic β-Enaminones as Anti-Breast Cancer Agents: In Vitro and Molecular Docking Studies. Chemistry and Biodiversity , vol.20, no.11 .

ATMACA İLHAN, H., İLHAN, M. S., DÜNDAR ÖZDOĞAN, B. A., & ZORA, M., (2023). Bioevaluation of Spiro N-Propargylic β-Enaminones as Anti-Breast Cancer Agents: In Vitro and Molecular Docking Studies. Chemistry and Biodiversity , vol.20, no.11.

ATMACA İLHAN, HARİKA Et Al. "Bioevaluation of Spiro N-Propargylic β-Enaminones as Anti-Breast Cancer Agents: In Vitro and Molecular Docking Studies," Chemistry and Biodiversity , vol.20, no.11, 2023

ATMACA İLHAN, HARİKA A. Et Al. "Bioevaluation of Spiro N-Propargylic β-Enaminones as Anti-Breast Cancer Agents: In Vitro and Molecular Docking Studies." Chemistry and Biodiversity , vol.20, no.11, 2023

ATMACA İLHAN, H. Et Al. (2023) . "Bioevaluation of Spiro N-Propargylic β-Enaminones as Anti-Breast Cancer Agents: In Vitro and Molecular Docking Studies." Chemistry and Biodiversity , vol.20, no.11.

@article{article, author={HARİKA ATMACA İLHAN Et Al. }, title={Bioevaluation of Spiro N-Propargylic β-Enaminones as Anti-Breast Cancer Agents: In Vitro and Molecular Docking Studies}, journal={Chemistry and Biodiversity}, year=2023}